Markets›NRIX

Nurix Therapeutics, Inc.

NRIX
23.01
-0.64 (-2.71%)
Closing price for Sep 25, 2026 from Polygon.io
All Annual reports Quarterly reports Current reports Other
FiledFormWhat it isPeriod
Mar 27, 2026 DEF 14A Proxy statement (shareholder vote) May 15, 2026 Read on sec.gov
Mar 28, 2025 DEF 14A Proxy statement (shareholder vote) May 19, 2025 Read on sec.gov
Nov 14, 2024 SC 13G/A Large shareholder ownership (amended) Read on sec.gov
Nov 14, 2024 SC 13G/A Large shareholder ownership (amended) Read on sec.gov
Nov 14, 2024 SC 13G/A Large shareholder ownership (amended) Read on sec.gov
Nov 14, 2024 SC 13G/A Large shareholder ownership (amended) Read on sec.gov
Nov 8, 2024 SC 13G Large shareholder ownership (passive) Read on sec.gov
Nov 7, 2024 SC 13G/A Large shareholder ownership (amended) Read on sec.gov

The most recent filings from SEC EDGAR. The annual report (10-K) is the most complete description of a company's business, risks and finances. How to read a 10-K. Every filing on EDGAR.